Chronic Wasting Disease in Deer: Prion Diagnostics and Surveillance Strategies

Chronic Wasting Disease (CWD) is a fatal, transmissible spongiform encephalopathy (TSE) affecting cervid species, including white-tailed deer (Odocoileus virginianus), mule deer (Odocoileus hemionus), elk (Cervus canadensis), and moose (Alces alces). The etiological agent is a prion: a misfolded, aggregation-prone isoform (PrP^Sc) of the host-encoded cellular prion protein (PrP^C). CWD is unique among TSEs for its high horizontal transmissibility via environmental shedding, leading to sustained epidemics in free-ranging and farmed populations. Effective management relies on accurate diagnostics and robust surveillance frameworks. This article provides a comprehensive review of CWD prion biology, diagnostic methodologies, and surveillance strategies within a One Health context, with emphasis on molecular and biophysical mechanisms.

Molecular Biology of Cervid Prions

The prion hypothesis posits that PrP^Sc acts as a template that catalyzes the conformational conversion of PrP^C into additional PrP^Sc through an autocatalytic, nucleation-dependent polymerization process. The conversion involves a shift from a predominantly alpha-helical structure to a beta-sheet-rich conformation, conferring resistance to proteolysis and standard sterilization.

Polymorphisms in the prion protein gene (PRNP) modulate susceptibility to CWD. In white-tailed deer, codons 95 and 96 are critical: the AF (Q95G96) and AC (Q95G96/Q95S96) haplotypes confer differential resistance. London et al. [1] demonstrated that the AF haplotype provides a measurable advantage over the AC haplotype against CWD, as evidenced by reduced PrP^Sc accumulation and prolonged incubation periods in experimental challenges. Similarly, Seerley et al. [2] identified novel PRNP variants in wild Montana mule deer, emphasizing the role of genetic background in population-level susceptibility. These findings inform selective breeding programs in captive herds and provide stratification criteria for surveillance.

Prion propagation in cervids occurs via both peripheral and central routes. After oral or nasal exposure, prions accumulate in gut-associated lymphoid tissues, then spread to the retropharyngeal lymph nodes (RPLN) and tonsils before entering the central nervous system. The long preclinical phase, often years, necessitates sampling of lymphoid tissues for early detection. Maternal transmission has been documented: Mori et al. [3] reported that maternal CWD infection restricts fetal head size in white-tailed deer, suggesting intrauterine effects of prion infection.

Diagnostic Platforms for CWD Detection

CWD diagnostics are categorized by target tissue, prion conformation, and detection sensitivity. The primary assays used in surveillance and research are enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC), and real-time quaking-induced conversion (RT-QuIC). Each has distinct operational principles, advantages, and limitations.

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA for CWD typically uses monoclonal antibodies directed against PrP^Sc. Following proteinase K digestion to remove PrP^C, the remaining protease-resistant PrP^Sc is captured and detected colorimetrically. ELISA is the standard high-throughput screening tool in many surveillance programs due to its scalability and automation. However, it requires fresh or frozen tissue (obex or RPLN) and is subject to false negatives in early infection when prion concentration is low. The assay format is analogous to p27 antigen detection for Feline Leukemia Virus (FeLV) (see Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus).

Immunohistochemistry (IHC)

IHC uses enzymatic or fluorescent labeling of antibodies bound to PrP^Sc in formalin-fixed, paraffin-embedded tissue sections. This method provides cellular resolution, allowing pathologists to assess the distribution and morphology of prion aggregates in lymphoid follicles and neuropil. IHC is considered the confirmatory gold standard for CWD. Munster et al. [4] optimized methods for preserved RPLN, showing that extended fixation and antigen retrieval protocols improve detection sensitivity in archival specimens. IHC is indispensable for retrospective studies and validation of field samples.

Real-Time Quaking-Induced Conversion (RT-QuIC)

RT-QuIC is a cell-free amplification assay that exploits the seeding activity of PrP^Sc. A dilute homogenate of suspect tissue is added to recombinant PrP^C substrate; cycles of shaking and incubation promote fibril formation, detected by thioflavin T fluorescence. RT-QuIC achieves attogram-level sensitivity and can detect prions in early preclinical stages and in biological fluids (e.g., cerebrospinal fluid, urine, feces). It is particularly suited for live-animal testing and environmental surveillance. The assay is less reliant on tissue integrity and can be applied to degraded samples.

Table 1 summarizes the key characteristics of these diagnostic platforms.

Table 1. Comparative Characteristics of Principal CWD Diagnostic Assays

Novel and Emerging Methods

Detection dog training aids: Mallikarjun et al. [5] assessed the impact of fecal volume on detection dog responses to CWD training aids. Canine olfaction may offer a non-invasive, field-deployable screening tool, though standardization and validation remain challenges.

Preserved tissue optimization: Munster et al. [4] demonstrated that prolonged formalin fixation reduces IHC signal, but optimized antigen retrieval (e.g., heat-induced epitope retrieval with citrate buffer) restores detectability in archival RPLN. This is critical for long-term surveillance programs that depend on biobanked specimens.

Surveillance Strategies and Spatial Epidemiology

CWD surveillance integrates diagnostic testing with population monitoring and spatial modeling. The design of surveillance systems depends on disease prevalence, geographic scale, and management objectives (e.g., eradication, containment, or prevalence reduction).

Sampling Frameworks

Surveillance can be passive (testing animals found dead or hunter-killed) or active (targeted sampling of live or culled animals). The Canadian Wildlife Health Cooperative has conducted 20 years of ungulate disease surveillance, documenting CWD expansion across provinces [6]. Their approach combines diagnostic necropsy with standardized data collection.

Active surveillance typically targets high-risk animals: adult males, which exhibit higher prevalence due to social interactions, and animals in known endemic zones. Janousek et al. [7] estimated GPS-based social aggregation metrics using collar data, enabling identification of contact networks that drive prion transmission. Such metrics inform spatial sampling intensity.

Modeling Transmission Dynamics

Agent-based models (ABMs) simulate individual-level interactions and disease progression. Wehr et al. [8] developed PAOvCWD, a statewide ABM for white-tailed deer in Pennsylvania, incorporating harvest data, habitat, and movement rules. The model predicts the efficacy of culling and vaccination scenarios (see Zimmerling and Napper [9] on oral vaccine deployment strategies).

Christensen et al. [10] modeled CWD transmission risk in mule deer as a function of habitat characteristics. They identified that higher risk correlates with riparian areas where deer congregate, facilitating environmental prion exposure. Such models prioritize surveillance zones for targeted testing.

Bagi et al. [11] reviewed how political barriers and land use impact wildlife health dynamics in the Carpathian Basin. Transboundary collaboration is essential: CWD does not respect administrative borders, and fragmented surveillance leads to delayed detection.

Spatial and Environmental Sampling

Environmental prion persistence poses unique challenges. Prions bind to soil minerals (e.g., montmorillonite) and remain infectious for years. Jorge et al. [12] examined the scavenging community in CWD-endemic regions, concluding that scavengers (e.g., coyotes, vultures) may mechanically move prions across landscapes, necessitating environmental monitoring.

Fecal sampling paired with RT-QuIC offers a non-invasive environmental detection method. However, Mallikarjun et al. [5] noted that fecal volume significantly affects detection dog accuracy, implying that biological variability must be accounted for in canine-based screening.

International Perspectives and Zoonotic Concerns

CWD has been detected in North America, South Korea [13], and Scandinavia. Choi et al. [13] reported CWD in farmed cervids in South Korea from 2001 to 2024, underscoring the global spread through live animal trade. The emergence in new regions demands rapid diagnostic capacity building.

Zoonotic potential remains a key One Health question. Hannaoui et al. [14] demonstrated limited transmission of cervid prions to nonhuman primates, suggesting a substantial species barrier. However, Frank et al. [15] warned of emerging risks at the vampire bat-prion interface, highlighting that prion ecology may intersect with novel hosts. Continuous surveillance and molecular characterization are necessary to monitor for adaptation.

Decision Workflow for CWD Surveillance

The following Mermaid diagram illustrates a diagnostic decision tree for CWD surveillance in free-ranging cervids.

flowchart TD
    A[Field sampling], > B{Animal status}
    B, >|Hunter-harvest or roadkill| C[RPLN / obex collection]
    B, >|Live capture| D[Biopsy of tonsil or RPLN]
    C, > E[Fresh tissue], > F[ELISA screening]
    C, > G[Fixed tissue], > H[IHC confirmation]
    D, > I[RT-QuIC on biopsy]
    F, > J{ELISA positive?}
    J, >|Yes| H
    J, >|No| K[Report as negative]
    H, > L{Positive by IHC?}
    L, >|Yes| M[Confirmed CWD case]
    L, >|No| N[Indeterminate / retest]
    I, > O{RT-QuIC positive?}
    O, >|Yes| M
    O, >|No| K
    M, > P[Geospatial metadata recording]
    P, > Q[Modeling and risk mapping]
    Q, > R[Targeted culling / surveillance density adjustment]

This workflow emphasizes the complementary roles of ELISA (high throughput), IHC (confirmatory), and RT-QuIC (high sensitivity for live animals). Surveillance data feed into spatial models that inform management actions.

Implications for Wildlife Management and One Health

CWD control in free-ranging populations is extraordinarily difficult due to environmental persistence and lack of effective vaccines or therapeutics. Zimmerling and Napper [9] modeled oral vaccine deployment strategies for cervids. While no licensed vaccine exists, theoretical models suggest that even partially effective vaccines could reduce prevalence if deployed strategically.

Maternal effects [3] and genetic resistance [1, 2] provide additional levers: selective culling or breeding for resistant genotypes may lower population susceptibility. However, the high cost and logistical complexity limit application to captive herds or localized wild populations.

From a One Health perspective, CWD surveillance must integrate veterinary, wildlife, and environmental health sectors. The diagnostic methods reviewed here are adaptable to other prion diseases (e.g., scrapie, bovine spongiform encephalopathy) but require species-specific optimization. The emergence of CWD in South Korea [13] highlights the need for global pathogen early warning systems, analogous to those for influenza Avian Influenza A(H5N1) in Poultry and Wild Birds.

The ongoing expansion of CWD underscores the urgency of refining diagnostic tools and surveillance frameworks. Advances in RT-QuIC and detection dog technology offer promise for non-invasive, high-throughput screening. Integration of habitat-based risk models [10] and social network analysis [7] can optimize resource allocation. Sustained investment in biobanking [4] and cross-border cooperation [11] remain critical.

References

[1] London EW, Roca AL, Ishida Y et al. Odocoileus virginianus PRNP sequencing reveals AF (Q(95)G(96)/H(95)G(96)) advantage over AC (Q(95)G(96)/Q(95)S(96)) against chronic wasting disease. Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42192487/

[2] Seerley AL, Rothfuss MT, Gray BM et al. Novel Prion Protein Gene (PRNP) Variants in Wild Montana Mule Deer. bioRxiv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41889842/

[3] Mori J, Perez-Girones SV, Latif T et al. Maternal chronic wasting disease infection restricts fetal head size in white-tailed deer (Odocoileus virginianus). Prion. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41772888/

[4] Munster A, Høy-Petersen J, Davis MA et al. Old nodes, new tricks: optimized methods for chronic wasting disease prion detection in preserved retropharyngeal lymph nodes. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42163590/

[5] Mallikarjun A, Wilson C, Charendoff I et al. Assessing the Impact of Fecal Volume on Detection Dog Responses to Chronic Wasting Disease Training Aids. J Wildl Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42161384/

[6] Schutten K, Shirose L, Stevens B et al. Twenty years of ungulate disease surveillance by the Canadian Wildlife Health Cooperative (2003-2022). PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41785212/

[7] Janousek WM, Cotterill GG, Lobo OJ et al. Estimating GPS-based social aggregation metrics using collar data. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41955232/

[8] Wehr NH, Rosenberry CS, Stainbrook D et al. Statewide agent-based model for management of chronic wasting disease in white-tailed deer: PAOvCWD. MethodsX. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41884661/

[9] Zimmerling AS, Napper S. Evaluating Potential Deployment Strategies for Oral Delivery of Vaccines for Cervids. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42222278/

[10] Christensen EM, Kleist NJ, Edmunds DR et al. Modeling chronic wasting disease transmission risk in mule deer related to habitat characteristics. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42054305/

[11] Bagi Z, Knop R, Tulcan C et al. Without Borders? The Impact of Political Barriers and Land Use on the Animal Health Dynamics and Genetic Structures of Large Game Species in the Carpathian Basin and Surrounding Regions-A Systematic Review. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41893719/

[12] Jorge MH, Jorge LA, Jarosinski D et al. White-tailed deer scavenging community in a chronic wasting disease-endemic region and considerations for prion movement. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42036448/

[13] Choi YP, Lee YR, Park HC et al. Chronic Wasting Disease in Farmed Cervids, South Korea, 2001-2024. Emerg Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41987004/

[14] Hannaoui S, Pritzkow S, Jürgens-Wemheuer WM et al. Limited transmission of cervid prions to nonhuman primates provides insights into the zoonotic potential of chronic wasting disease. Sci Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202024/

[15] Frank LE, Bartz JC, Larsen PA. Emerging risks at the vampire bat-prion interface: implications for wildlife, livestock, and public health. J Mammal. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41918996/